Associations between Specific Dissociative Symptoms and Symptom Subsets and Anti-Depressant Response to Ketamine

Shovestul, B., Jaso, B., Luckenbaugh, D., Park, L., Niciu, M., & Zarate, C. | Biological Psychiatry | 15 May 2017

Ketamine as a Treatment for Adolescent Major Depressive Disorder

Dwyer, J., Sanacora, G., & Bloch, M. | Biological Psychiatry | 15 May 2017

Clinical Predictors of an Antisuicidal Response to Ketamine

Yarrington, J., Ballard, E., Luckenbaugh, D., Niciu, M., Lener, M., Kadriu, B., ... & Zarate, C. | Biological Psychiatry | 15 May 2017

Mood Dependent Effects of Ketamine on REM Eye Movements in Patients with Treatment Resistant Depression (TRD)

Hejazi, N., Yu, K., Park, L., Duncan, W., & Zarate, C. | Biological Psychiatry | 15 May 2017

Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial

Grunebaum, M. F., Ellis, S. P., Keilp, J. G., Moitra, V. K., Cooper, T. B., Marver, J. E., ... & Mann, J. J. | Bipolar Disorders | 28 April 2017

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin

Schartner, M. M., Carhart-Harris, R. L., Barrett, A. B., Seth, A. K., & Muthukumaraswamy, S. D. | Scientific Reports | 19 April 2017

Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder

Adams, T. G., Bloch, M. H., & Pittenger, C. | Journal of clinical psychopharmacology | 1 March 2017

Rapid antidepressant effect of ketamine correlates with astroglial plasticity in the hippocampus

Ardalan, M., Rafati, A. H., Nyengaard, J. R., & Wegener, G. | British Journal of Pharmacology | 8 February 2017

Sub-anesthetic doses of ketamine exert antidepressant-like effects and upregulate the expression of glutamate transporters in the hippocampus of rats

Zhu, X., Ye, G., Wang, Z., Luo, J., & Hao, X. | Neuroscience Letters | 3 February 2017

Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task

Rychlik, M., Bollen, E., & Rygula, R. | Psychopharmacology | 1 February 2017

Prophylactic Ketamine Attenuates Learned Fear

McGowan, J. C., LaGamma, C. T., Lim, S. C., Tsitsiklis, M., Neria, Y., Brachman, R. A., & Denny, C. A. | Neuropsychopharmacology | 27 January 2017

Reply to: Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion

da Frota Ribeiro, C. M., Sanacora, G., & Ostroff, R. | Biological Psychiatry | 23 January 2017

Administration of ketamine for unipolar and bipolar depression

Kraus, C., Rabl, U., Vanicek, T., Carlberg, L., Popovic, A., Spies, M., ... & Willeit, M. | International Journal of Psychiatry in Clinical Practice | 18 January 2017

Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature

Grady, S. E., Marsh, T. A., Tenhouse, A., & Klein, K. | Mental Health Clinician | 1 January 2017

Ketamine Mechanism of Action: Separating the Wheat from the Chaff

Gould, T. D., Zanos, P., & Zarate, C. A. | Neuropsychopharmacology | 1 January 2017

Ketamine accelerates fear extinction via mTORC1 signaling

Girgenti, M. J., Ghosal, S., LoPresto, D., Taylor, J. R., & Duman, R. S. | Neurobiology of Disease | 30 December 2016

Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder

Vande Voort, J. L., Ballard, E. D., Luckenbaugh, D. A., Bernert, R. A., Richards, E. M., Niciu, M. J., ... & Zarate, C. A. | Journal of clinical psychiatry | 6 December 2016

Ketamine for Treatment-Resistant Depression

Mathew, S. J., & Zarate Jr, C. A. | Springer International Publishing | 1 December 2016

Ketamine’s Mechanisms of Rapid Antidepressant Activity: Evidence from Preclinical Studies

Hermes, G., & Sanacora, G. | Ketamine for Treatment-Resistant Depression | 30 November 2016

Integrative analysis of sex differences in the rapid antidepressant effects of ketamine in preclinical models for individualized clinical outcomes

Saland, S. K., Duclot, F., & Kabbaj, M. | Current Opinion in Behavioral Sciences | 26 November 2016

Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant

Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L. | Neuroscience Bulletin | 22 November 2016

Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects

Lepow, L., Luckenbaugh, D. A., Park, L., Henter, I. D., & Zarate, C. A. | Journal of psychiatric research | 21 November 2016

Ketamine: The Glutamatergic Antidepressant and Its Efficacy

Tracy, D. K., Caddy, C., & Shergill, S. S. | Melatonin, Neuroprotective Agents and Antidepressant Therapy | 18 November 2016

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. | Current Opinion in Behavioral Sciences | 15 November 2016

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies

Han, Y., Chen, J., Zou, D., Zheng, P., Li, Q., Wang, H., ... & Xie, P. | Neuropsychiatric Disease and Treatment | 3 November 2016